International Heart Congress, May 24 - 25, 2023 | Tokyo, Japan.

As a member of the organizing committee, it is my absolute pleasure to welcome you all to the much-awaited scientific feast ‘Heart Congress 2023’ to be held in the beautiful city of Tokyo, Japan.

Cardiovascular Medicine is the most paced field of Medicine with innovative research and cutting technology. You will have an opportunity to listen to keynote speakers and world-renowned experts in the field of Cardiovascular Medicine. There will keynote lectures, plenary scientific sessions and posters. I can assure you 2 days of a high-class learning experience blended with professional networking as well as plenty of time to explore city of historical culture and mouth-watering cuisine.

The conference organizers are working hard to put together a conference worth remembering.

I personally cannot wait to see you all in May 2023.

International Heart Congress, May 24 - 25, 2023 | Tokyo, Japan | Hybrid Event

Dear congress visitors, speakers and chairs, it is an honor and pleasure to participate in this prestigious event. The field of cardiovascular and heart research is fastly growing with many innovations being discovered along the way. Other promising ideas and hypothesis are being discussed and tested among our courageous researchers. This opens new opportunities to better detect, treat, and manage heart and cardiovascular diseases, with the hope that in the future curative approaches will be discovered. The theme of our conference this year is ” Advances in Cardiology: Research and Innovations”. The Conference will provide an opportunity for participants to present their work and provide an updated on areas related to both theoretical and applied research in the field of heart and cardiovascular research. Furthermore, the Conference will provide a nourishing environment for visitors to exchange idea, knowledge, information, learn new things and possibly build new collaborations based on the common interested between them. For the International Heart Congress 2023 I would be very glad if we could reach a record number of participants, presentations and if this conference would lead to the establishment of fruitful interactions among participants and new cultural proposals that can grow up for the positive development of the Conference and for the intellectual growth of all the participants. Finally, I would like to thank all the participants, visitors and a special thanks goes to the organizing Committee and everyone who helped facilitate this conference for the tremendous human effort they made.

3rd Edition of Cardiology World Conference, September 14 -15, 2022 | Paris, France

Dear participants of the World Conference on Cardiology.

Cardiovascular disease continues to lead the way in complications and deaths among adults around the world. In developed countries, the incidence rate has decreased, while in developing countries, these rates are somewhat different. Numerous international studies are being carried out to improve the diagnosis, treatment and, most importantly, the prevention of cardiovascular diseases. As data accumulates, international recommendations are updated. It is safe to say that international treatment standards are applied in all countries. But there is a lot of work to be done to introduce innovative technologies in cardiology.

I believe that scientific and educational conferences with the exchange of opinions of specialists from different countries are positively reflected  in the accumulation of experience in the fight against cardiovascular diseases.

I call on my colleagues to actively participate in the work of the World Conference on Cardiology 2022 and wish you success.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

One of the themes of this conference is that of myocardial ischaemia and infarction. At first glance, this would seem to represent purely a repetition of our previous focus on the traditional theme of a common spectrum of cardiovascular disorders driven by the traditional risk factors of hypertension, smoking, diabetes and poor diet, and emerging mainly in middle-aged men. Our therapeutic discussion 30 years ago would have emphasised coronary revascularization above all. However, much has changed. In Western societies, emergence of coronary atheroma-related disease has generally been delayed, if not prevented, while an emerging epidemic threatens the Third World. We have finally learned the importance of inflammation as a key component of the pathogenesis of atherogenesis and myocardial Welcome Message ischaemia, and are beginning to refine our pharmacotherapy to accommodate the recognition of its potential effectiveness and the emergence of “new” forms of acute heart disease which occur mainly in women. I welcome you to the ischaemia/infarction section of the Conference, and trust that you will find our discussions exciting and providing of a better guide to future treatment.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

Dear conference participants and colleagues, I am glad to welcome you to the international conference on cardiology. Cardiovascular diseases are still the main cause of complications and mortality in adults. Moreover, this global trend is observed in both developed and developing countries of the world. Conducted international clinical studies to identify risk factors, primary and secondary prevention of cardiovascular diseases. Annually, the results of major projects on the effectiveness of drugs and new technologies are published. In the 21st century, digital technologies are increasingly used in cardiology. The international conference will highlight various areas in cardiology, which will help in the practical work of specialists. I wish you fruitful work.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

Dear congress visitors, It gives me great pleasure to write a few welcome notes. The field of cardiovascular biomarker research is entering a new, exciting era with the introduction of the concept of ‘personalized medicine’ in therapeutic treatment guidance. With a variety of new cardiovascular biomarkers, and assertions of their respective independent associations with outcome, it becomes increasingly difficult to select the biomarker with the strongest diagnostic as well as prognostic value. One can expect that the increasing use of cardiovascular biomarkers, accompanying traditional diagnostic and prognostic measures, for specific cardiovascular diseases, will lead to their almost crucial role in clinical decision making. However, the search for an ideal biomarker, or set of biomarkers, requires a systematic and rigorous approach to biomarker studies, more emphasis on Welcome Message prospective studies, and use of external validation cohorts. Accomplishment of the previous will lead to improved quality of diagnostic and, even more important, prognostic biomarker research in the future, and will be required if we want to bring this clinically important research field forward.

Cardiology World Conference, October 24-25, 2019 | Tokyo, Japan

Dear congress participants, it is an honor and pleasure to write a few welcome notes. During the last decade, research in cardiovascular field has dramatically increased leading to a substantial improvement in the treatment and the outcome of patients affected with cardiovascular diseases. The main theme of the “Cardiology World Conference” (CWC 2019) will be the “Advances in Cardiology: Research and Innovations”. Latest breaking trials, innovations and hot topics will be discussed in depth during the event involving different fields and specialties contributing to cardiovascular research. Hence, we strongly believe that CWC 2019 will represent a major platform for promoting and advancing cardiology in its dynamic field. We look forward to welcoming you in Tokyo (Japan), for what promises to be an unforgettable Conference. See you there!